Mounjaro Weight Loss Injection
weight loss of 15-22.5% of body weight over 72 weeks
Mounjaro (tirzepatide) is a medication used to lower blood sugar levels in adults with type 2 diabetes.
Average weight loss of 15-22.5% of body weight over 72 weeks, with some individuals experiencing greater losses when combined with lifestyle changes
- Purpose:
- Mounjaro activates two receptors called GLP-1 and GIP, increasing the level of incretins (hormones) in the body. It helps your body produce more insulin when needed, reduces liver glucose production, and slows down food digestion.
- Mounjaro is administered once weekly.
- Usage:
- Take it alongside a reduced-calorie diet.
- Engage in increased physical activity.
- Eligibility: It’s intended for use in overweight or obese adults.
- Significant weight loss potential
- Improves blood sugar control and reduces cardiovascular risk factors
- Once-weekly dosing for convenience
GI Effects
- Nausea (20-40%)
- Diarrhea (18-23%)
- Vomiting (10-18%)- Constipation (10-16%)
- Decreased appetite (10-15%)
Rare Side Effects
- Pancreatitis (<0.1%)
- Gallbladder problems, including gallstones (<0.5%)
- Severe allergic reactions (anaphylaxis) (<0.1%)
- Kidney problems (<0.1%)